Evidence map›Paper›PMID 22027590›Full record

ArticleNature communications2011

Synapse microarray identification of small molecules that enhance synaptogenesis.

Peng Shi, Mark A Scott, Balaram Ghosh, Dongpeng Wan, Zachary Wissner-Gross, Ralph Mazitschek, Stephen J Haggarty, Mehmet Fatih Yanik

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2024
    Article
  4. Review
  5. Article
  6. Human mini-brain models.Nature biomedical engineering · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Stem cells technology: a powerful tool behind new brain treatments.Drug delivery and translational research · 2018
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Compartmentalized Microfluidic Platforms: The Unrivaled Breakthrough of In Vitro Tools for Neurobiological Research.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Peng ShiDepartment of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Mark A Scott
Balaram Ghosh
Dongpeng Wan
Zachary Wissner-Gross
Ralph Mazitschek
Stephen J Haggarty
Mehmet Fatih Yanik
Massachusetts Institute of Technology · USCenter for Systems Biology · USHarvard University · USBroad Institute · US

Funding

Small-molecule probes of chromatin-mediated neuroplasticityR01DA028301 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI HAGGARTY, STEPHEN J · 2009 to 2013
$3.0M
Functional Genomics of Neuroplasticity in SchizophreniaR01MH095088 · NIMH · BROAD INSTITUTE, INC. · PI HAGGARTY, STEPHEN J · 2011 to 2014
$2.5M
High-throughput single-cell-resolution genetic and pharmacological screens usingR01NS066352 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YANIK, MEHMET FATIH · 2009 to 2012
$1.7M
NIDA NIH HHS R01 DA028301NIMH NIH HHS R01 MH095088NINDS NIH HHS R01 NS066352
6 · The paper itself

Abstract

Synaptic function is affected in many brain diseases and disorders. Technologies for large-scale synapse assays can facilitate identification of drug leads. Here we report a 'synapse microarray' technology that enables ultra-sensitive, high-throughput and quantitative screening of synaptogenesis. Our platform enables the induction of synaptic structures in regular arrays by precise positioning of non-neuronal cells expressing synaptic proteins, while allowing neurites to grow freely around these cells. The technology increases by tenfold the sensitivity of the traditional assays, and simultaneously decreases the time required to capture synaptogenic events by an order of magnitude. It is readily incorporated into multiwell formats compatible with industrial high-throughput screening platforms. Using this technology, we screened a chemical library, and identified novel histone deacetylase (HDAC) inhibitors that improve neuroligin-1-induced synaptogenesis by modulating class-I HDACs. We also found a structure-activity relationship for designing novel potent histone deacetylase inhibitors, which can be applied towards development of new therapeutics.

Indexed as

Cell LineCoculture TechniquesFibroblastsFluorescenceHumansImmunohistochemistryNeuronsSynapses

Identifiers

PMID22027590
PMCPMC3544154
OpenAlexW2145003526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.